3710 results for «2021»
3710 results
Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology
27 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...

Contemporary procedural practice for TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Case-based challenging heart team decisions in combined structural heart diseases
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this case-based session on combined structural heart diseases to discover what is the heart team approach for complex structure heart diseases, as well as how to manage a patient with multiple diseases.

Valve-in-valve TAVI
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on valve-in-valve TAVI to learn how to identify patient at risk of coronary obstruction and PPM post VIV procedure, and discover how to protect the coronary arteries and how to minimise PPM during the surgery.

Edge-to-edge mitral repair
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on edge-to-edge mitral repair to learn more about the indication and the patient selection for percutaneous mitral valve treatment for secondary MR, and discover some interesting tips and tricks in difficult situations during MitraClip.

TAVI and coronary artery disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on TAVI and coronary artery disease to learn about the different modalities to assess for CAD in patients planned for TAVI, when to revascularise significant CAD in patients undergoing TAVI, and how to facilitate coronary access after TAVI.

Update on new guidelines for management of patients with valvular heart disease
25 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on the management of patients with valvular heart disease to learn about the new guidelines, and discover how to apply them to your daily practice.

Bicuspid aortic valves: where do we stand?
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session to learn more about bicuspid aortic valves: understand patient selection for TAVI, explore sizing and valve selection, and discover the key procedural steps for TAVI in bicuspid AV.

A case-based discussion on left atrial appendage closure
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this case-based session on left atrial appendage closure to learn more about patient selection and pre- / post-procedural planning for LAAO, and discover how to perform a safe and effective procedure.

Case-based challenging edge-to-edge mitral repair
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session on mitral valve repair to learn how to successfully perform this procedure, especially in patients with challenging anatomies, and how to face any possible complications.

Case-based challenging TAVI
26 Sep 2021 – From PCR Tokyo Valves 2021
Watch this session with challenging TAVI cases to learn more about indication and choice of treatment for patients with aortic stenosis, and discover some interesting tips and tricks to face tough situations.

Tailoring mitral repair and optimising clinical outcomes using MitraClip G4
27 Sep 2021 – From PCR Tokyo Valves 2021
Using the one-year results of the EXPAND study and the 30-day results of the EXPAND G4 study, this session highlights the value of the latest generation of MitraClip technologies, providing an overview of the strengths of the MitraClip G4 and its practical use on 2 case...

Why durability matters: lifetime management considerations for supra-annular TAVR
26 Sep 2021 – From PCR Tokyo Valves 2021
In this session, the speakers address the problem of the evolution of clinical data for TAVI from extreme to low risk based on a number of studies on the subject, such as CoreValve Pivotal Study, Partner Study, SURTAVI Study, or Evolut Low-Risk Study, and then focus...

Antegrade CTO intervention: the essentials you need to learn
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session on antegrade CTO intervention to learn the basics and hardware required to perform antegrade CTO technique and the various techniques and devices for a successful surgery, as well as to know some of the complications that may occur during the procedure.

Contemporary challenges in STEMI management
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session on contemporary challenges in STEMI management to review the role for complete revascularisation in STEMI, to discuss challenges faced in managing STEMI in the COVID era, and to understand how to approach coronary calcification in STEMI.

How to? Learning useful techniques of PCI in daily practice
08 Oct 2021 – From AICT-AsiaPCR 2021
Watch this session to learn some useful PCI techniques that may increase your procedural success rate, and discover these techniques in a step-by-step manner, made easy to understand.

Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...

Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.

Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
